Over the next five years, funds will support trainees in the Surgeon Scientist Training Program, Research Fellowships, CPD courses, and a new Research and Innovation Grant, all specifically focused on urologic oncology.
In partnership with the Canadian Urologic Oncology Group (CUOG) and its partners, we aim to certify Urologic Oncology as an Area of Focus Competence (AFC) through the Royal College of Physicians and Surgeons. Since we have the largest fellowship program in urologic oncology, the University of Toronto will serve as the institutional leader for the national program.
Urological cancers represent almost 24% of Canadian malignancies and the practice of oncology among urologists has always represented – and will continue to represent – a significant proportion of urological practice. With these new funds, we will make significant investment in specialty training and evidence-based research in urologic oncology, with the ultimate goal of improving patient care and outcomes. I am optimistic and enthusiastic about promise of this program and the impact it will have: the creation of a recognized subspecialty, dedicated and concentrated efforts for complex care cases, and expansion of the reach and access to therapies, novel agents, and best practices beyond the current and traditional practices.
Please join me in extending our sincere thanks to Astellas for their leadership and continued support of the UofT Division of Urology!
Neil E. Fleshner
Martin Barkin Chair in Urological Research